Niagen Bioscience Inc Niagen Bioscience Inc

Niagen Bioscience Inc

NAGE

Rank in Stocks #17383
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus... Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Share Price
$2.07
Last synced: 2026-11-13
Market Cap
$163.44M
Change (1 day)
-3.05%
Change (1 year)
-69.23%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Niagen Bioscience Inc (NAGE)
Operating Margin as of November 2026 TTM: 2.28%
According to Niagen Bioscience Inc's latest financial reports, its current operating margin (TTM) is 2.28%. At the end of 2025 the company had an operating margin of 11.05%.
Operating Margin history for Niagen Bioscience Inc from 2007 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 2.28% -79.37%
2025 11.05% 42.40%
2024 7.76% -215.82%
2023 -6.70% -74.08%
2022 -25.85% -35.60%
2021 -40.14% 19.82%
2020 -33.50% -50.46%
2019 -67.62% -35.67%
2018 -105.12% 36.08%
2017 -77.25% 476.06%
2016 -13.41% 16.10%
2015 -11.55% -66.19%
2014 -34.16% -20.87%
2013 -43.17% -56.92%
2012 -100.22% 3.38%
2011 -96.94% 263.62%
2010 -26.66% 72.56%
2009 -15.45% -66.27%
2008 -45.80% 0.00%
2007 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -185.70%
US
33.87% -85.14%
US
-116.04% -150.89%
US
25.57% -88.79%
AU
31.23% -86.30%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Niagen Bioscience Inc's operating margin

What is Niagen Bioscience Inc's operating margin?

Niagen Bioscience Inc's operating margin is 2.28%, as of Nov 2026.

What was Niagen Bioscience Inc's operating margin in 2025?

In 2025, Niagen Bioscience Inc's operating margin was 11.05%, compared with 7.76% in 2024.

How has Niagen Bioscience Inc's operating margin changed since 2020?

From 2020 to 2025, Niagen Bioscience Inc's operating margin was highest in 2025 (11.05%) and lowest in 2021 (-40.14%).

How does Niagen Bioscience Inc's operating margin compare with similar companies?

Niagen Bioscience Inc's operating margin (2.28%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.